• About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU
  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

IPHAR (Innovative Pharmacology Research, LLC ) Skolkovo FASIE

IPHAR (Innovative Pharmacology Research, LLC )

  • About us
    • History
    • Advantages
    • IPHAR company group
    • Board of directors
    • Scientific council
  • Investment projects
    • Preclinical stage
    • Clinical stage
    • Information for investors
  • Services
    • Drug development
    • Pharmaceutical technology
    • Pharmaceutical development
    • Preclinical trials
    • Pharmaceutical and
      pharmacokinetic analysis
    • Clinical trials
  • Video
  • Skolkovo Collective Use Center
  • Contacts
  • Job offerings
  • RURU

День: 14.11.2022

Томские ученые ведут испытания нового лекарства от болезни Паркинсона

14.11.2022No category

Томская компания “Инновационные Фармакологические Разработки” (ООО “Ифар”) планирует начать испытания нового лекарства от болезни Паркинсона с участием пациентов в 2023 году.

Categories

  • No category
  • Exhibitions
November 2022
M T W T F S S
« Oct   Dec »
 123456
78910111213
14151617181920
21222324252627
282930  

© 2025 IPHAR (Innovative Pharmacology Research, LLC ) All Rights Reserved.